Vertigo clinical trials

The registry lists 187 studies for Vertigo across more than 10 countries. 27 are recruiting or about to start. 85 of them are mainly about Vertigo (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its narrower condition Benign Paroxysmal Positional Vertigo too: 230 studies, 37 open.

Get an email when these change. Save the Vertigo studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 109
Status unknown: 31
Recruiting: 15
Not yet recruiting: 10
Active, not recruiting: 7
Withdrawn: 7

Phase

Phase 2: 17
Phase 3: 14
Phase 4: 12
Phase 1: 5
Early Phase 1: 1

Where

United States: 41
Turkey: 15
Pakistan: 12
China: 12
France: 11
Denmark: 8

Who runs them

Riphah International University (8) · Otonomy, Inc. (5) · Aalborg University Hospital (5) · Otolith Labs (5) · University Hospital, Strasbourg, France (5) · Sound Pharmaceuticals, Incorporated (5) · University of Sao Paulo General Hospital (3) · Second Affiliated Hospital, School of Medicine, Zhejiang University (3)

What is being tested here

Drugs under test in Vertigo studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Vitamin D	1	0	1
Calcium	1	0	1
Diazepam	1	1	1
Ebselen	0	2	5
Dexamethasone	0	3	4
Sustained-Exposure Dexamethasone Formulation OTO-104	0	3	4
Lamotrigine	0	0	2
Methylprednisolone	0	1	2
Caffeine	0	0	2
Montelukast	0	0	1

Drug classes tested here Anxiolytics 1 open · Corticosteroids 6

Coming up

3phase 3 studies under way

8studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8, phase 3 first

Dec 2026SPI-1005 for the Treatment of Meniere's Disease (Open Label) · Phase 3 · Sound Pharmaceuticals, Incorporated
Dec 2026Comparison of Two Mechanical Rotation Chairs With Diagnostics of Benign Paroxysmal Positional Vertigo. · Aalborg University Hospital
Dec 2026Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo · Valenta Pharm JSC
Jan 2027Reducing Vertigo Associated With MRI Machines · Johns Hopkins University
Apr 2027Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes · IRCCS San Raffaele
May 2027The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer · Rigshospitalet, Denmark
Oct 2027Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device · Stanford University
Oct 2027Quantitative Eye Movement Measurements in Patients with Acute Vestibular Syndrome · Alexander Tarnutzer

Who these studies take

Of the 15 Vertigo studies recruiting now, 8 (53%) set no upper age limit and 4 (27%) stop at 75 or younger. 2 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (47%) take healthy volunteers.

Recruiting studies that take each age, of 15
Age	Women	Men
10	2 (13%)	2 (13%)
18	12 (80%)	12 (80%)
30	13 (87%)	13 (87%)
40	13 (87%)	13 (87%)
50	13 (87%)	13 (87%)
65	12 (80%)	12 (80%)
75	11 (73%)	11 (73%)
85	10 (67%)	10 (67%)

Across all 187 studies, recruiting or not: 40% stop at 75 or younger and 24% at 65; 9% take children; 1% are for women only and 0% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vertigo studies take

Of 64 interventional studies with no phase under Vertigo, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	19 mo6–28 · 64 studies	—	21 mo5–30 · 60 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 187. Browse all 187 → or search them.